TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Vaccinium Invest AB
Closing information (x1000 NOK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
25,216
|
47,002
|
0 |
| Financial expenses |
0
|
1
|
151 |
| Earnings before taxes |
14,500
|
5,628
|
-121 |
| EBITDA |
3,933
|
-643
|
-19 |
| Total assets |
14,358
|
10,299
|
3,773 |
| Current assets |
14,208
|
10,144
|
3,630 |
| Current liabilities |
908
|
0
|
1 |
| Equity capital |
13,451
|
10,299
|
3,772 |
| - share capital |
50
|
52
|
48 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
93.7%
|
100%
|
100.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
57.5%
|
12.0% | |
| Return on assets (ROA) |
101.0%
|
54.7%
|
0.8% |
| Current ratio | 1564.8% | 363000% | |
| Return on equity (ROE) |
107.8%
|
54.6%
|
-3.2% |
| Change turnover |
-20,362
|
47,002
|
0 |
| Change turnover % | -45% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.